UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.
UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.